Winton Group LTD Natera, Inc. Transaction History

Winton Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$59.21 - $92.9 $481,554 - $755,555	8,133 New	8,133 $743,000
Q1 2023 May 12, 2023	BUY	$36.57 - $58.29 $11,080 - $17,661	303 Added 1.96%	15,754 $874,000
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $158,343 - $222,014	4,634 Added 42.84%	15,451 $620,000
Q3 2022 Nov 10, 2022	SELL	$36.93 - $56.68 $324,171 - $497,537	-8,778 Reduced 44.8%	10,817 $474,000
Q2 2022 Aug 10, 2022	BUY	$28.13 - $44.54 $93,616 - $148,229	3,328 Added 20.46%	19,595 $694,000
Q1 2022 May 11, 2022	BUY	$30.32 - $91.33 $218,394 - $657,849	7,203 Added 79.47%	16,267 $662,000
Q4 2021 Feb 10, 2022	SELL	$86.26 - $119.0 $69,353 - $95,676	-804 Reduced 8.15%	9,064 $846,000
Q3 2021 Oct 28, 2021	SELL	$100.17 - $126.36 $200,139 - $252,467	-1,998 Reduced 16.84%	9,868 $1.1 Million
Q2 2021 Aug 10, 2021	SELL	$86.05 - $119.72 $53,953 - $75,064	-627 Reduced 5.02%	11,866 $1.35 Million
Q1 2021 Jul 21, 2021	SELL	$91.47 - $124.36 $488,266 - $663,833	-5,338 Reduced 29.94%	12,493 $1.27 Million
Q4 2020 Feb 12, 2021	SELL	$66.66 - $111.74 $2.69 Million - $4.5 Million	-40,307 Reduced 69.33%	17,831 $1.78 Million
Q3 2020 Oct 30, 2020	BUY	$45.89 - $72.67 $2.67 Million - $4.22 Million	58,138 New	58,138 $4.2 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.